878 related articles for article (PubMed ID: 28072753)
1. Engraftment Site and Effectiveness of the Pan-Caspase Inhibitor F573 to Improve Engraftment in Mouse and Human Islet Transplantation in Mice.
Pepper AR; Bruni A; Pawlick R; Wink J; Rafiei Y; Gala-Lopez B; Bral M; Abualhassan N; Kin T; Shapiro AMJ
Transplantation; 2017 Oct; 101(10):2321-2329. PubMed ID: 28072753
[TBL] [Abstract][Full Text] [Related]
2. Short-term culture with the caspase inhibitor z-VAD.fmk reduces beta cell apoptosis in transplanted islets and improves the metabolic outcome of the graft.
Montolio M; Téllez N; Biarnés M; Soler J; Montanya E
Cell Transplant; 2005; 14(1):59-65. PubMed ID: 15789663
[TBL] [Abstract][Full Text] [Related]
3. A Novel Subcutaneous Site of Islet Transplantation Superior to the Liver.
Yasunami Y; Nakafusa Y; Nitta N; Nakamura M; Goto M; Ono J; Taniguchi M
Transplantation; 2018 Jun; 102(6):945-952. PubMed ID: 29521877
[TBL] [Abstract][Full Text] [Related]
4. Porcine islet graft function is affected by pretreatment with a caspase-3 inhibitor.
Brandhorst D; Kumarasamy V; Maatoui A; Alt A; Bretzel RG; Brandhorst H
Cell Transplant; 2006; 15(4):311-7. PubMed ID: 16898224
[TBL] [Abstract][Full Text] [Related]
5. Red Ginseng Administration Before Islet Isolation Attenuates Apoptosis and Improves Islet Function and Transplant Outcome in a Syngeneic Mouse Marginal Islet Mass Model.
Kim JS; Jang HJ; Kim SS; Oh MY; Kim HJ; Lee SY; Eom DW; Ham JY; Han DJ
Transplant Proc; 2016 May; 48(4):1258-65. PubMed ID: 27320599
[TBL] [Abstract][Full Text] [Related]
6. HMGB1-Mediated Early Loss of Transplanted Islets Is Prevented by Anti-IL-6R Antibody in Mice.
Itoh T; Nitta T; Nishinakamura H; Kojima D; Mera T; Ono J; Kodama S; Yasunami Y
Pancreas; 2015 Jan; 44(1):166-71. PubMed ID: 25058889
[TBL] [Abstract][Full Text] [Related]
7. Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device.
Pepper AR; Pawlick R; Gala-Lopez B; MacGillivary A; Mazzuca DM; White DJ; Toleikis PM; Shapiro AM
Transplantation; 2015 Nov; 99(11):2294-300. PubMed ID: 26308506
[TBL] [Abstract][Full Text] [Related]
8. Harnessing the Foreign Body Reaction in Marginal Mass Device-less Subcutaneous Islet Transplantation in Mice.
Pepper AR; Pawlick R; Bruni A; Gala-Lopez B; Wink J; Rafiei Y; Bral M; Abualhassan N; Shapiro AM
Transplantation; 2016 Jul; 100(7):1474-9. PubMed ID: 27136258
[TBL] [Abstract][Full Text] [Related]
9. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
10. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
Emamaullee JA; Stanton L; Schur C; Shapiro AM
Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806
[TBL] [Abstract][Full Text] [Related]
11. Early TLR4 Blockade Attenuates Sterile Inflammation-mediated Stress in Islets During Isolation and Promotes Successful Transplant Outcomes.
Chang CA; Murphy K; Kane RR; Lawrence MC; Naziruddin B
Transplantation; 2018 Sep; 102(9):1505-1513. PubMed ID: 29787520
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide, a long-acting human glucagon-like peptide 1 analog, improves glucose homeostasis in marginal mass islet transplantation in mice.
Merani S; Truong W; Emamaullee JA; Toso C; Knudsen LB; Shapiro AM
Endocrinology; 2008 Sep; 149(9):4322-8. PubMed ID: 18511515
[TBL] [Abstract][Full Text] [Related]
13. BMX-001, a novel redox-active metalloporphyrin, improves islet function and engraftment in a murine transplant model.
Bruni A; Pepper AR; Pawlick RL; Gala-Lopez B; Gamble A; Kin T; Malcolm AJ; Jones C; Piganelli JD; Crapo JD; Shapiro AMJ
Am J Transplant; 2018 Aug; 18(8):1879-1889. PubMed ID: 29464912
[TBL] [Abstract][Full Text] [Related]
14. Transplantation sites for human and murine islets.
Stokes RA; Cheng K; Lalwani A; Swarbrick MM; Thomas HE; Loudovaris T; Kay TW; Hawthorne WJ; O'Connell PJ; Gunton JE
Diabetologia; 2017 Oct; 60(10):1961-1971. PubMed ID: 28735354
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast populated collagen matrix promotes islet survival and reduces the number of islets required for diabetes reversal.
Jalili RB; Moeen Rezakhanlou A; Hosseini-Tabatabaei A; Ao Z; Warnock GL; Ghahary A
J Cell Physiol; 2011 Jul; 226(7):1813-9. PubMed ID: 21506112
[TBL] [Abstract][Full Text] [Related]
16. Anti-caspase-3 preconditioning increases proinsulin secretion and deteriorates posttransplant function of isolated human islets.
Brandhorst D; Brandhorst H; Maataoui V; Maataoui A; Johnson PR
Apoptosis; 2013 Jun; 18(6):681-8. PubMed ID: 23536200
[TBL] [Abstract][Full Text] [Related]
17. The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice.
Emamaullee JA; Davis J; Pawlick R; Toso C; Merani S; Cai SX; Tseng B; Shapiro AM
Diabetes; 2008 Jun; 57(6):1556-66. PubMed ID: 18356409
[TBL] [Abstract][Full Text] [Related]
18. Alpha-melanocyte stimulating hormone preserves islet graft survival through down-regulation of Toll-like receptors.
Jung EJ; Kim SC; Jeong SH; Lee JY; Han DJ
Transplant Proc; 2012 May; 44(4):1086-90. PubMed ID: 22564632
[TBL] [Abstract][Full Text] [Related]
19. Donor pretreatment with DHMEQ improves islet transplantation.
Takahashi T; Matsumoto S; Matsushita M; Kamachi H; Tsuruga Y; Kasai H; Watanabe M; Ozaki M; Furukawa H; Umezawa K; Todo S
J Surg Res; 2010 Sep; 163(1):e23-34. PubMed ID: 20638688
[TBL] [Abstract][Full Text] [Related]
20. Polymer scaffolds as synthetic microenvironments for extrahepatic islet transplantation.
Blomeier H; Zhang X; Rives C; Brissova M; Hughes E; Baker M; Powers AC; Kaufman DB; Shea LD; Lowe WL
Transplantation; 2006 Aug; 82(4):452-9. PubMed ID: 16926587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
